Discover
IMRX
Immuneering Corporation
3.94
2 x 3.22
2 x 5.52
bid
ask
+
0.20
5.35%
2 @ 04:01 PM
3.94 +0.00 (0.00%)
| Ytd | -40.12% | |
| 1y | -36.86% |
3.68
day range
3.96
3.74
52 week range
8.33
| Open | 3.75 | Prev Close | 3.74 | Low | 3.68 | High | 3.96 | Mkt Cap | 254.91M |
| Vol | 709.72K | Avg Vol | 708.12K | EPS | -0.98 | P/E | N/A | Forward P/E | -1.34 |
| Beta | -0.40 | Short Ratio | 1.19 | Inst. Own | 30.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 4.60 | 200-d Avg | 4.99 | 1yr Est | 12.42 |
| Income Statement | |||
| Operating Expenses | 19.00M | ||
| Research and Development Expense | 14.00M | ||
| Selling, General and Administrative Expense | 5.00M | ||
| Operating Income | -19.00M | ||
| Net Income | -17.27M | ||
| Net Income Common Stock | -17.27M | ||
| Net Income Common Stock (USD) | -17.27M | ||
| Consolidated Income | -17.27M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -17.27M | ||
| Earning Before Interest & Taxes (USD) | -17.27M | ||
| Weighted Average Shares | 64.70M | ||
| Weighted Average Shares Diluted | 64.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.32M | ||
| Cash and Equivalents (USD) | 41.32M | ||
| Investments | 141.35M | ||
| Investments Current | 108.58M | ||
| Investments Non-Current | 32.77M | ||
| Current Assets | 157.99M | ||
| Property, Plant & Equipment Net | 4.02M | ||
| Total Assets | 202.06M | ||
| Debt Current | 428.96K | ||
| Total Debt | 3.63M | ||
| Current Liabilities | 8.12M | ||
| Debt Non-Current | 3.20M | ||
| Total Liabilities | 11.32M | ||
| Accumulated Retained Earnings (Deficit) | -311.05M | ||
| Accumulated Other Comprehensive Income | -406.24K | ||
| Shareholders Equity | 190.74M | ||
| Shareholders Equity (USD) | 190.74M | ||
| Assets Non-Current | 44.06M | ||
| Total Debt (USD) | 3.63M | ||
| Goodwill and Intangible Assets | 7.00M | ||
| Liabilities Non-Current | 3.20M | ||
| Trade and Non-Trade Payables | 3.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 185.91K | ||
| Net Cash Flow from Financing | 24.61K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.00M | ||
| Capital Expenditure | -27.37K | ||
| Issuance (Purchase) of Equity Shares | 24.61K | ||
| Net Cash Flow from Investing | 10.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.51M | ||
| Net Cash Flow from Operations | -16.50M | ||
| Share Based Compensation | 1.63M | ||